CoChat

Effect of Hallucinogens on Unconditioned Behavior

Open access
Halberstadt, Adam L., Geyer, Mark A. · 2016 · Current Topics in Behavioral Neurosciences
Cited by 106

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Because of the ethical and regulatory hurdles associated with human studies, much of what is known about the psychopharmacology of hallucinogens has been derived from animal models. However, developing reliable animal models has proven to be a challenging task due to the complexity and variability of hallucinogen effects in humans. This chapter focuses on three animal models that are frequently used to test the effects of hallucinogens on unconditioned behavior: head twitch response (HTR), prepulse inhibition of startle (PPI), and exploratory behavior. The HTR has demonstrated considerable utility in the neurochemical actions of hallucinogens. However, the latter two models have clearer conceptual bridges to human phenomenology. Consistent with the known mechanism of action of hallucinogens in humans, the behavioral effects of hallucinogens in rodents are mediated primarily by activation of 5-HT2A receptors. There is evidence, however, that other receptors may play secondary roles. The structure–activity relationships (SAR) of hallucinogens are reviewed in relation to each model, with a focus on the HTR in rats and mice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/7854_2016_466

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 255

  1. Abramson HA, Sklarofsky B, Baron MO, Fremont-Smith N (1958) Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide). Arch Neurol Psychiatry 79:201–207 · DOI
  2. Acuña-Castillo C, Villalobos C, Moya PR, Sáez P, Cassels BK, Huidobro-Toro JP (2002) Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT2A and 5-HT2C receptors. Br J Pharmacol 136:510–519 · DOI
  3. Adams LM, Geyer MA (1985a) Effects of DOM and DMT in a proposed animal model of hallucinogenic activity. Prog Neuropsychopharmacol Biol Psychiatry 9:121–132 · DOI
  4. Adams LM, Geyer MA (1985b) A proposed animal model for hallucinogens based on LSD’s effects on patterns of exploration in rats. Behav Neurosci 99:881–900 · doi:10.1037/0735-7044.99.5.881
  5. Aghajanian GK, Marek GJ (1997) Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36:589–599 · DOI · Paper page
  6. Allen JA, Yadav PN, Setola V, Farrell M, Roth BL (2011) Schizophrenia risk gene CAV1 is both pro-psychotic and required for atypical antipsychotic drug actions in vivo. Transl Psychiatry 1:e33 · DOI · Paper page
  7. Appel JB, West WB, Rolandi WG, Alici T, Pechersky K (1999) Increasing the selectivity of drug discrimination procedures. Pharmacol Biochem Behav 64:353–358 · DOI
  8. Arnt J, Hyttel J (1989) Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI. Eur J Pharmacol 161:45–51 · DOI
  9. Axelrod J (1962) The enzymatic N-methylation of serotonin and other amines. J Pharmacol Exp Ther 138:28–33 · DOI · Paper page
  10. Baisley SK, Fallace KL, Rajbhandari AK, Bakshi VP (2012) Mutual independence of 5-HT2 and α1 noradrenergic receptors in mediating deficits in sensorimotor gating. Psychopharmacology 220:465–479 · DOI
  11. Baladi MG, Newman AH, France CP (2010) Dopamine D3 receptors mediate the discriminative stimulus effects of quinpirole in free-feeding rats. J Pharmacol Exp Ther 332:308–315 · DOI
  12. Balsara JJ, Bapat TR, Nandal NV, Gada VP, Chandorkar AG (1986) Head-twitch response induced by ergometrine in mice: behavioural evidence for direct stimulation of central 5-hydroxytryptamine receptors by ergometrine. Psychopharmacology 88:275–278 · doi:10.1007/bf00180824
  13. Baumann MH, Clark RD, Rothman RB (2008) Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain. Pharmacol Biochem Behav 90:208–217 · DOI
  14. Bedard P, Pycock CJ (1977) “Wet-dog” shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity. Neuropharmacology 16:663–670 · DOI · Paper page
  15. Benes H, Deissler A, Rodenbeck A, Engfer A, Kohnen R (2006) Lisuride treatment of Restless Legs Syndrome: first studies with monotherapy in de novo patients and in combination with levodopa in advanced disease. J Neural Transm 113:87–92 · DOI
  16. Berendsen HH, Broekkamp CL (1990) Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice. Br J Pharmacol 101:667–673 · DOI
  17. Berendsen HH, Jenck F, Broekkamp CL (1989) Selective activation of 5HT1A receptors induces lower lip retraction in the rat. Pharmacol Biochem Behav 33:821–827 · DOI · Paper page
  18. Berlyne DE (1950) Novelty and curiosity as determinants of exploratory behavior. Br J Psychol 41:68–80
  19. Berlyne DE (1955) The arousal and satiation of perceptual curiosity in the rat. J Comp Physiol Psychol 48:238–246 · DOI · Paper page
  20. Berlyne DE (1960) Conflict, arousal and curiosity. Macgraw-Hill, New-York · DOI · Paper page
  21. Berlyne DE (1966) Curiosity and exploration. Science 153:25–33 · DOI · Paper page
  22. Bigwood J, Ott J, Thompson C, Neely P (1979) Entheogenic effects of ergonovine. J Psychedelic Drugs 11:147–149 · doi:10.1080/02791072.1979.10472099
  23. Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Marcellino D, Ciruela F, Agnati LF, Fuxe K (2010) Dopamine D2 and 5-hydroxytryptamine 5-HT2A receptors assemble into functionally interacting heteromers. Biochem Biophys Res Commun 401:605–610 · DOI
  24. Braden MR, Parrish JC, Naylor JC, Nichols DE (2006) Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists. Mol Pharmacol 70:1956–1964 · DOI · Paper page
  25. Braff DL, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339–343 · DOI · Paper page
  26. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234–258 · DOI · Paper page
  27. Brandt SD, Kavanagh PV, Westphal F, Elliott SP, Wallach J, Colestock T, Burrow TE, Chapman SJ, Stratford A, Nichols DE, Halberstadt AL (2017) Return of the lysergamides. Part II: analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2’S,4’S)-lysergic acid 2,4-dimethylazetidide (LSZ). Drug Test Anal 9:38–50 · DOI · Paper page
  28. Brandt SD, Kavanagh PV, Westphal F, Stratford A, Elliott SP, Hoang K, Wallach J, Halberstadt AL (2016) Return of the lysergamides. Part I: Analytical and behavioral characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Drug Test Anal 8:891–902 · DOI
  29. Brauer LH, Johanson CE, Schuster CR, Rothman RB, de Wit H (1996) Evaluation of phentermine and fenfluramine, alone and in combination, in normal, healthy volunteers. Neuropsychopharmacology 14:233–241 · DOI
  30. Bräuer D, Strobel A, Hensch T, Diers K, Lesch KP, Brocke B (2009) Genetic variation of serotonin receptor function affects prepulse inhibition of the startle. J Neural Transm 116:607–613 · DOI
  31. Brea J, Castro M, Loza MI, Masaguer CF, Raviña E, Dezi C, Pastor M, Sanz F, Cabrero-Castel A, Galán-Rodríguez B, Fernández-Espejo E, Maldonado R, Robledo P (2006) QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine. Neuropharmacology 51:251–262 · DOI
  32. Brimblecombe RE (1963) Effects of psychotropic drugs on open-field behaviour in rats. Psychopharmacologia 4:139–147 · doi:10.1007/bf00413331
  33. Brookshire BR, Jones SR (2009) Direct and indirect 5-HT receptor agonists produce gender-specific effects on locomotor and vertical activities in C57 BL/6J mice. Pharmacol Biochem Behav 94:194–203 · DOI
  34. Burris KD, Breeding M, Sanders-Bush E (1991) (+)Lysergic acid diethylamide, but not its nonhallucinogenic congeners, is a potent serotonin 5HT1C receptor agonist. J Pharmacol Exp Ther 258:891–896 · DOI · Paper page
  35. Callaway CW, Wing LL, Geyer MA (1990) Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats. J Pharmacol Exp Ther 254:456–464 · DOI · Paper page
  36. Canal CE, Morgan D (2012) Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model. Drug Test Anal 4:556–576 · DOI · Paper page
  37. Canal CE, Olaghere da Silva UB, Gresch PJ, Watt EE, Sanders-Bush E, Airey DC (2010) The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen. Psychopharmacology 209:163–174 · DOI · Paper page
  38. Canal CE, Booth RG, Morgan D (2013) Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model. Neuropharmacology 70:112–121 · DOI · Paper page
  39. Carbonaro TM, Eshleman AJ, Forster MJ, Cheng K, Rice KC, Gatch MB (2015) The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N, N-dimethyltryptamine and N, N-diisopropyltryptamine in rats and mice. Psychopharmacology 232:275–284 · DOI · Paper page
  40. Carlsson ML, Burstein ES, Kloberg A, Hansson S, Schedwin A, Nilsson M, Rung JP, Carlsson A (2011) I. In vivo evidence for partial agonist effects of (−)-OSU6162 and (+)-OSU6162 on 5-HT2A serotonin receptors. J Neural Transm 118:1511–1522 · DOI
  41. Ciccocioppo R, Angeletti S, Colombo G, Gessa G, Massi M (1999) Autoradiographic analysis of 5-HT2A binding sites in the brain of Sardinian alcohol-preferring and nonpreferring rats. Eur J Pharmacol 373:13–19 · DOI
  42. Colpaert FC, Niemegeers CJ, Janssen PA (1982) A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist. J Pharmacol Exp Ther 221:206–214 · DOI · Paper page
  43. Corne SJ, Pickering RW (1967) A possible correlation between drug-induced hallucinations in man and a behavioural response in mice. Psychopharmacologia 11:65–78 · DOI · Paper page
  44. Corne SJ, Pickering RW, Warner BT (1963) A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br J Pharmacol Chemother 20:106–120 · DOI · Paper page
  45. Cussac D, Boutet-Robinet E, Ailhaud MC, Newman-Tancredi A, Martel JC, Danty N, Rauly-Lestienne I (2008) Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells. Eur J Pharmacol 594:32–38 · DOI
  46. Dandiya PC, Gupta BD, Gupta ML, Patni SK (1969) Effects of LSD on open field performance in rats. Psychopharmacologia 15:333–340 · doi:10.1007/bf00401687
  47. Darmani NA (1998a) Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice. Pharmacol Biochem Behav 60:83–90 · DOI
  48. Darmani NA (1998b) The silent and selective 5-HT1A antagonist, WAY 100635, produces via an indirect mechanism, a 5-HT2A receptor-mediated behaviour in mice during the day but not at night. Short communication. J Neural Transm 105:635–643 · DOI
  49. Darmani NA, Pandya DK (2000) Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice. J Neural Transm 107:931–945 · DOI
  50. Darmani NA, Martin BR, Pandey U, Glennon RA (1990) Do functional relationships exist between 5-HT1A and 5-HT2 receptors? Pharmacol Biochem Behav 36:901–906 · DOI · Paper page
  51. Darmani NA, Mock OB, Towns LC, Gerdes CF (1994) The head-twitch response in the least shrew (Cryptotis parva) is a 5-HT2- and not a 5-HT1C-mediated phenomenon. Pharmacol Biochem Behav 48:383–396 · DOI
  52. Darmani NA, Shaddy J, Gerdes CF (1996) Differential ontogenesis of three DOI-induced behaviors in mice. Physiol Behav 60:1495–1500 · DOI
  53. Darmani NA, Janoyan JJ, Kumar N, Crim JL (2003) Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover. Pharmacol Biochem Behav 75:777–787 · DOI
  54. Delille HK, Becker JM, Burkhardt S, Bleher B, Terstappen GC, Schmidt M, Meyer AH, Unger L, Marek GJ, Mezler M (2012) Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades. Neuropharmacology 62:2184–2191 · DOI
  55. Delille HK, Mezler M, Marek GJ (2013) The two faces of the pharmacological interaction of mGlu2 and 5-HT2A—relevance of receptor heterocomplexes and interaction through functional brain pathways. Neuropharmacology 70:296–305 · DOI
  56. Dodge R, Louttit CM (1926) Modification of the pattern of the guinea pig’s reflex response to noise. J Com Psychol 60:267–285 · doi:10.1037/h0072276
  57. Drust EG, Connor JD (1983) Pharmacological analysis of shaking behavior induced by enkephalins, thyrotropin-releasing hormone or serotonin in rats: evidence for different mechanisms. J Pharmacol Exp Ther 224:148–154 · doi:10.1016/s0022-3565(25)33443-9
  58. Dulawa SC, Geyer MA (2000) Effects of strain and serotonergic agents on prepulse inhibition and habituation in mice. Neuropharmacology 39:2170–2179 · DOI
  59. Dulawa SC, Gross C, Stark KL, Hen R, Geyer MA (2000) Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology 22:650–659 · DOI
  60. Dursun SM, Handley SL (1996) Similarities in the pharmacology of spontaneous and DOI-induced head-shakes suggest 5HT2A receptors are active under physiological conditions. Psychopharmacology 128:198–205 · DOI
  61. Egan CT, Herrick-Davis K, Miller K, Glennon RA, Teitler M (1998) Agonist activity of LSD and lisuride at cloned 5HT2Aand 5HT2Creceptors. Psychopharmacology 136:409–414 · DOI
  62. Egashira N, Shirakawa A, Okuno R, Mishima K, Iwasaki K, Oishi R, Fujiwara M (2011) Role of endocannabinoid and glutamatergic systems in DOI-induced head-twitch response in mice. Pharmacol Biochem Behav 99:52–58 · DOI
  63. Ettrup A, Holm S, Hansen M, Wasim M, Santini MA, Palner M, Madsen J, Svarer C, Kristensen JL, Knudsen GM (2013) Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [11C]Cimbi-36. Mol Imaging Biol 15:376–383 · DOI
  64. Fantegrossi WE, Kiessel CL, Leach PT, Van Martin C, Karabenick RL, Chen X, Ohizumi Y, Ullrich T, Rice KC, Woods JH (2004) Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice. Psychopharmacology 173:270–277 · DOI
  65. Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH (2005a) Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats. Psychopharmacology 181:496–503 · DOI
  66. Fantegrossi WE, Kiessel CL, De la Garza R, Woods JH (2005b) Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse. Psychopharmacology 181:529–536 · doi:10.1007/s00213-005-0005-8
  67. Fantegrossi WE, Harrington AW, Kiessel CL, Eckler JR, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH (2006) Hallucinogen-like actions of 5-methoxy-N, N-diisopropyltryptamine in mice and rats. Pharmacol Biochem Behav 83:122–129 · DOI
  68. Fantegrossi WE, Reissig CJ, Katz EB, Yarosh HL, Rice KC, Winter JC (2008) Hallucinogen-like effects of N, N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents. Pharmacol Biochem Behav 88:358–365 · DOI
  69. Fantegrossi WE, Simoneau J, Cohen MS, Zimmerman SM, Henson CM, Rice KC, Woods JH (2010) Interaction of 5-HT2A and 5-HT2C receptors in R(−)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice. J Pharmacol Exp Ther 335:728–734 · DOI
  70. Fantegrossi WE, Gray BW, Bailey JM, Smith DA, Hansen M, Kristensen JL (2014) Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT2A receptors, in mice. Psychopharmacology 232:1039–1047 · DOI · Paper page
  71. Filip M, Bubar MJ, Cunningham KA (2004) Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J Pharmacol Exp Ther 310:1246–1254 · DOI
  72. Fiorella D, Rabin RA, Winter JC (1995) Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: reassessment of LSD false positives. Psychopharmacology 121:357–363 · DOI
  73. Fleshler M (1965) Adequate acoustic stimulus for the startle reflex in the rat. J Com Physiol Psychol 60:200–207 · DOI
  74. Fletcher PJ, Tampakeras M, Sinyard J, Slassi A, Isaac M, Higgins GA (2009) Characterizing the effects of 5-HT2C receptor ligands on motor activity and feeding behaviour in 5-HT2C receptor knockout mice. Neuropharmacology 57:259–267 · DOI
  75. Fowler H (1965) Curiosity and exploratory behavior. Macmillan, New York
  76. Fox MA, French HT, LaPorte JL, Blackler AR, Murphy DL (2010a) The serotonin 5-HT2A receptor agonist TCB-2: a behavioral and neurophysiological analysis. Psychopharmacology 212:13–23 · DOI
  77. Fox MA, Stein AR, French HT, Murphy DL (2010b) Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT). Br J Pharmacol 159:879–887 · DOI
  78. Freedland CS, Mansbach RS (1999) Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture. Drug Alcohol Depend 54:183–194 · DOI
  79. Garcia EE, Smith RL, Sanders-Bush E (2007) Role of Gq protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane. Neuropharmacology 52:1671–1677 · DOI
  80. Gewirtz JC, Marek GJ (2000) Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors. Neuropsychopharmacology 23:569–576 · DOI · Paper page
  81. Geyer MA (1998) Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research. Pharmacopsychiatry 31:73–79 · DOI · Paper page
  82. Geyer MA, Krebs KM (1994) Serotonin receptor involvement in an animal model of the acute effects of hallucinogens. NIDA Res Monograph Ser 146:124–156
  83. Geyer MA, Paulus MP (1992) Multivariate and nonlinear approaches to characterizing drug effects on the locomotor and investigatory behavior of rats. NIDA Res Monogr 124:203–235
  84. Geyer MA, Russo PV, Masten VL (1986) Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacol Biochem Behav 25:277–288 · DOI · Paper page
  85. Geyer MA, Russo PV, Segal DS, Kuczenski R (1987) Effects of apomorphine and amphetamine on patterns of locomotor and investigatory behavior in rats. Pharmacol Biochem Behav 28:393–399 · DOI · Paper page
  86. Glennon RA (1991) Discriminative stimulus properties of hallucinogens and related designer drugs. NIDA Res Monogr 116:25–44
  87. Glennon RA, Hauck AE (1985) Mechanistic studies on DOM as a discriminative stimulus. Pharmacol Biochem Behav 23:937–941 · DOI
  88. Glennon RA, Young R, Rosecrans JA (1982a) Discriminative stimulus properties of DOM and several molecular modifications. Pharmacol Biochem Behav 16:553–556 · doi:10.1016/0091-3057(82)90413-0
  89. Glennon RA, Young R, Rosecrans JA (1982b) A comparison of the behavioral effects of DOM homologs. Pharmacol Biochem Behav 16:557–559 · DOI
  90. Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505–2511 · DOI · Paper page
  91. Glennon RA, McKenney JD, Lyon RA, Titeler M (1986) 5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues. J Med Chem 29:194–199 · DOI
  92. Glennon RA, Titeler M, Seggel MR, Lyon RA (1987) N-Methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. J Med Chem 30:930–932 · DOI
  93. Glennon RA, Titeler M, Lyon RA, Slusher RM (1988) N, N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin. J Med Chem 31:867–870 · DOI
  94. Gogos A, Bogeski M, van den Buuse M (2008) Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology. Behav Pharmacol 19:548–561 · DOI
  95. Gold LH, Koob GF, Geyer MA (1988) Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats. J Pharmacol Exp Ther 247:547–555 · DOI
  96. Gorzalka BB, Hill MN, Sun JC (2005) Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes. Eur J Pharmacol 516:28–33 · DOI
  97. Gouzoulis-Mayfrank E, Heekeren K, Thelen B, Lindenblatt H, Kovar KA, Sass H, Geyer MA (1998) Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans. Behav Pharmacol 9:561–566 · DOI · Paper page
  98. Grillon C, Ameli R, Charney DS, Krystal J, Braff DL (1992) Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry 32:939–943 · DOI · Paper page
  99. Grotewiel MS, Chu H, Sanders-Bush E (1994) m-Chlorophenylpiperazine and m-trifluoromethylphenylpiperazine are partial agonists at cloned 5-HT2A receptors expressed in fibroblasts. J Pharmacol Exp Ther 271:1122–1126 · DOI
  100. Gupta BD, Dandiya PC, Gupta ML, Gabba AK (1971) An examination of the effect of central nervous system stimulant and anti-depressant drugs on open field performance in rats. Eur J Pharmacol 13:341–346 · doi:10.1016/0014-2999(71)90224-x
  101. Halberstadt AL (2016) Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N, N-dimethyltryptamine. Pharmacol Biochem Behav 143:1–10 · DOI · Paper page
  102. Halberstadt AL, Geyer MA (2010) LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor. Psychopharmacology 208:179–189 · DOI · Paper page
  103. Halberstadt AL, Geyer MA (2011) Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology 61:364–381 · DOI · Paper page
  104. Halberstadt AL, Geyer MA (2013) Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement. Psychopharmacology 227:727–739 · DOI · Paper page
  105. Halberstadt AL, Geyer MA (2014) Effect of the hallucinogen 2C-I and two superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology 77:200–207 · DOI · Paper page
  106. Halberstadt AL, Buell MR, Masten V, Risbrough VB, Geyer MA (2008) Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacology 201:55–66 · DOI · Paper page
  107. Halberstadt AL, van der Heijden I, Ruderman M, Risbrough VB, Gingrich JA, Geyer MA, Powell SB (2009) Opposing effects of 5-HT2A and 5-HT2C receptors on locomotor activity in mice. Neuropsychopharmacology 34:1958–1967 · DOI · Paper page
  108. Halberstadt AL, Powell SB, Geyer MA (2013) Role of the 5-HT2A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice. Neuropharmacology 70:218–227 · DOI
  109. Halberstadt AL, Sindhunata I, Scheffers K, Flynn AD, Sharp RF, Geyer MA, Young JW (2016a) Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice. Neuropharmacology 107:364–375 · DOI · Paper page
  110. Halberstadt AL, Slepak N, Hyun J, Buell MR, Powell SB (2016b) The novel ketamine analog methoxetamine produces dissociative-like behavioral effects in rodents. Psychopharmacology 233:1215–1225 · DOI · Paper page
  111. Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Bräuner-Osborne H, Kristensen JL (2014) Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists. ACS Chem Neurosci 5:243–249 · DOI · Paper page
  112. Hawkins MF, Uzelac SM, Baumeister AA, Hearn JK, Broussard JI, Guillot TS (2002) Behavioral responses to stress following central and peripheral injection of the 5-HT2 agonist DOI. Pharmacol Biochem Behav 73:537–544 · DOI
  113. Hazama K, Hayata-Takano A, Uetsuki K, Kasai A, Encho N, Shintani N, Nagayasu K, Hashimoto R, Reglodi D, Miyakawa T, Nakazawa T, Baba A, Hashimoto H (2014) Increased behavioral and neuronal responses to a hallucinogenic drug in PACAP heterozygous mutant mice. PLoS ONE 9:e89153 · DOI
  114. Heal DJ, Philpot J, O’Shaughnessy KM, Davies CL (1986) The influence of central noradrenergic function on 5-HT2-mediated head-twitch responses in mice: possible implications for the actions of antidepressant drugs. Psychopharmacology 89:414–420 · doi:10.1007/bf02412113
  115. Heekeren K, Neukirch A, Daumann J, Stoll M, Obradovic M, Kovar KA, Geyer MA, Gouzoulis-Mayfrank E (2007) Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N, N-dimethyltryptamine (DMT) models of psychosis. J Psychopharmacol 21:312–320 · DOI · Paper page
  116. Herrmann WM, Horowski R, Dannehl K, Kramer U, Lurati K (1977) Clinical effectiveness of lisuride hydrogen maleate: a double-blind trial versus methysergide. Headache 17:54–60 · DOI · Paper page
  117. Hillegaart V, Estival A, Ahlenius S (1996) Evidence for specific involvement of 5-HT1A and 5-HT2A/C receptors in the expression of patterns of spontaneous motor activity of the rat. Eur J Pharmacol 295:155–161 · DOI
  118. Hiramatsu M, Nabeshima T, Kameyama T, Maeda Y, Cho AK (1989) The effect of optical isomers of 3,4-methylenedioxymethamphetamine (MDMA) on stereotyped behavior in rats. Pharmacol Biochem Behav 33:343–347 · DOI
  119. Hoffman HS, Ison JR (1980) Reflex modification in the domain of startle: I. Some empirical findings and their implications for how the nervous system processes sensory input. Psychol Rev 87:175–189 · doi:10.1037/0033-295x.87.2.175 · Paper page
  120. Hoffman HS, Searle JL (1965) Acoustic variables in the modification of startle reaction in the rat. J Comp Physiol Psychol 60:53–58 · DOI · Paper page
  121. Hoffman HS, Searle JL (1968) Acoustic and temporal factors in the evocation of startle. J Acoustic Soc Am 43:269–282 · DOI · Paper page
  122. Holohean AM, White FJ, Appel JB (1982) Dopaminergic and serotonergic mediation of the discriminable effects of ergot alkaloids. Eur J Pharmacol 81:595–602 · DOI
  123. Huang JT, Ho BT (1973) Differentiation of pressor and behavioral effects of d-amphetamine and 2,5-dimethoxy-4-methylamphetamine (STP) by cinanserin. Can J Physiol Pharmacol 51:976–980 · doi:10.1139/y73-146
  124. Hughes RN (1972) Chlordiazepoxide modified exploration in rats. Psychopharmacologia 24:462–469 · DOI
  125. Jacobs BL, Trulson ME, Stern WC (1976) An animal behavior model for studying the actions of LSD and related hallucinogens. Science 194:741–743 · DOI
  126. Jacobs BL, Trulson ME, Stern WC (1977) Behavioral effects of LSD in the cat: proposal of an animal behavior model for studying the actions of hallucinogenic drugs. Brain Res 132:301–314 · DOI
  127. Johansson C, Jackson DM, Zhang J, Svensson L (1995) Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats. Pharmacol Biochem Behav 52:649–654 · DOI
  128. Johnson MP, Hoffman AJ, Nichols DE (1986) Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices. Eur J Pharmacol 132:269–276 · DOI · Paper page
  129. Kantor RE, Dudlettes SD, Shulgin AT (1980) 5-Methoxy-α-methyltryptamine (α, O-dimethylserotonin) a hallucinogenic homolog of serotonin. Biol Psychiatry 15:349–352
  130. Kärkkäinen J, Forsström T, Tornaeus J, Wähälä K, Kiuru P, Honkanen A, Stenman UH, Turpeinen U, Hesso A (2005) Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues. Scand J Clin Lab Invest 65:189–199 · DOI · Paper page
  131. Keller DL, Umbreit WW (1956) Permanent alteration of behavior in mice by chemical and psychological means. Science 124:723–724 · DOI
  132. Kennett GA, Wood MD, Glen A, Grewal S, Forbes I, Gadre A, Blackburn TP (1994) In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist. Br J Pharmacol 111:797–802 · DOI · Paper page
  133. Kimura KK, Akai TT, Nakamura KK, Yamaguchi MM, Nakagawa H, Oshino NN (1991) Dual activation by lisuride of central serotonin 5-HT1A and dopamine D2 receptor sites: drug discrimination and receptor binding studies. Behav Pharmacol 2:105–112
  134. Klodzinska A, Bijak M, Tokarski K, Pilc A (2002) Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of in mice. Pharmacol Biochem Behav 73:327–332 · DOI
  135. Knauer CS, Campbell JE, Chio CL, Fitzgerald LW (2009) Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors. Naunyn Schmiedebergs Arch Pharmacol 379:461–471 · DOI
  136. Kometer M, Schmidt A, Jäncke L, Vollenweider FX (2013) Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations. J Neurosci 33:10544–10551 · DOI · Paper page
  137. Krebs KM, Geyer MA (1994) Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats. Psychopharmacology 113:429–437 · DOI
  138. Krebs-Thomson K, Geyer MA (1996) The role of 5-HT1A receptors in the locomotor-suppressant effects of LSD: WAY-100635 studies of 8-OH-DPAT, DOI and LSD in rats. Behav Pharmacol 7:551–559
  139. Krebs-Thomson K, Lehmann-Masten V, Naiem S, Paulus MP, Geyer MA (1998a) Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin. Eur J Pharmacol 343:135–143 · DOI
  140. Krebs-Thomson K, Paulus MP, Geyer MA (1998b) Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors. Neuropsychopharmacology 18:339–351 · DOI
  141. Krebs-Thomson K, Ruiz EM, Masten V, Buell M, Geyer MA (2006) The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats. Psychopharmacology 189:319–329 · DOI
  142. Kurrasch-Orbaugh DM, Watts VJ, Barker EL, Nichols DE (2003) Serotonin 5-hydroxytryptamine2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves. J Pharmacol Exp Ther 304:229–237 · DOI · Paper page
  143. Lehmann-Masten VD, Geyer MA (1991) Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats. Neuropharmacology 30:629–636 · DOI
  144. Leng A, Ouagazzal A, Feldon J, Higgins GA (2003) Effect of the 5-HT6 receptor antagonists Ro04-6790 and Ro65-7199 on latent inhibition and prepulse inhibition in the rat: comparison to clozapine. Pharmacol Biochem Behav 75:281–288 · DOI
  145. Leysen JE, Niemegeers CJ, Van Nueten JM, Laduron PM (1982) [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. Mol Pharmacol 21:301–314 · DOI · Paper page
  146. Lucki I, Minugh-Purvis N (1987) Serotonin-induced head shaking behavior in rats does not involve receptors located in the frontal cortex. Brain Res 420:403–406 · DOI
  147. Lucki I, Nobler MS, Frazer A (1984) Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. J Pharmacol Exp Ther 228:133–139 · DOI · Paper page
  148. Lukasiewicz S, Polit A, Kędracka-Krok S, Wędzony K, Maćkowiak M, Dziedzicka-Wasylewska M (2010) Hetero-dimerization of serotonin 5-HT2A and dopamine D2 receptors. Biochim Biophys Acta 1803:1347–1358 · DOI
  149. Lyon RA, Glennon RA, Titeler M (1986) 3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors. Psychopharmacology 88:525–526
  150. Mackeprang T, Kristiansen KT, Glenthoj BY (2002) Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients. Biol Psychiatry 52:863–873 · DOI
  151. Malick JB, Doren E, Barnett A (1977) Quipazine-induced head-twitch in mice. Pharmacol Biochem Behav 6:325–329 · DOI
  152. Marini JL, Jacobs BL, Sheard MH, Trulson ME (1981) Activity of a non-hallucinogenic ergoline derivative, lisuride, in an animal behavior model for hallucinogens. Psychopharmacology 73:328–331 · DOI
  153. Marquis KL, Sabb AL, Logue SF, Brennan JA, Piesla MJ, Comery TA, Grauer SM, Ashby CR Jr, Nguyen HQ, Dawson LA, Barrett JE, Stack G, Meltzer HY, Harrison BL, Rosenzweig-Lipson S (2007) WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity. J Pharmacol Exp Ther 320:486–496 · DOI
  154. Matthews WD, Smith CD (1980) Pharmacological profile of a model for central serotonin receptor activation. Life Sci 26:1397–1403 · DOI
  155. Mavlyutov TA, Epstein ML, Liu P, Verbny YI, Ziskind-Conhaim L, Ruoho AE (2012) Development of the sigma-1 receptor in C-terminals of motoneurons and colocalization with the N, N’-dimethyltryptamine forming enzyme, indole-N-methyl transferase. Neuroscience 206:60–68 · DOI · Paper page
  156. May JA, Dantanarayana AP, Zinke PW, McLaughlin MA, Sharif NA (2006) 1-((S)-2-aminopropyl)-1H-indazol-6-ol: a potent peripherally acting 5-HT2 receptor agonist with ocular hypotensive activity. J Med Chem 49:318–328 · DOI
  157. McKenna DJ, Repke DB, Lo L, Peroutka SJ (1990) Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes. Neuropharmacology 29(3):193–198 · DOI · Paper page
  158. McOmish CE, Lira A, Hanks JB, Gingrich JA (2012) Clozapine-induced locomotor suppression is mediated by 5-HT2A receptors in the forebrain. Neuropsychopharmacology 37:2747–2755 · DOI
  159. Mittman SM, Geyer MA (1989) Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens. Psychopharmacology 98:321–329 · DOI
  160. Mittman SM, Geyer MA (1991) Disassociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol. Psychopharmacology 105:69–76 · DOI
  161. Molinaro G, Traficante A, Riozzi B, Di Menna L, Curto M, Pallottino S, Nicoletti F, Bruno V, Battaglia G (2009) Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice. Mol Pharmacol 76:379–387 · DOI
  162. Moreno JL, Holloway T, Albizu L, Sealfon SC, González-Maeso J (2011) Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists. Neurosci Lett 493:76–79 · DOI · Paper page
  163. Mos J, Olivier B, Tulp MThM (1992) Ethopharmacological studies differentiate the effects of various serotonergic compounds on agression in rats. Drug Dev Res 26:343–360 · DOI
  164. Moya PR, Berg KA, Gutiérrez-Hernandez MA, Sáez-Briones P, Reyes-Parada M, Cassels BK, Clarke WP (2007) Functional selectivity of hallucinogenic phenethylamine and phenylisopropylamine derivatives at human 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors. J Pharmacol Exp Ther 321:1054–1061 · DOI
  165. Murnane KS, Fantegrossi WE, Godfrey JR, Banks ML, Howell LL (2010) Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys. J Pharmacol Exp Ther 334:642–650 · DOI
  166. Muschamp JW, Regina MJ, Hull EM, Winter JC, Rabin RA (2004) Lysergic acid diethylamide and [−]-2,5-dimethoxy-4-methylamphetamine increase extracellular glutamate in rat prefrontal cortex. Brain Res 1023:134–140 · DOI
  167. Nakagawasai O, Murata A, Arai Y, Ohba A, Wakui K, Mitazaki S, Niijima F, Tan-No K, Tadano T (2007) Enhanced head-twitch response to 5-HT-related agonists in thiamine-deficient mice. J Neural Transm (Vienna) 114:1003–1010 · DOI
  168. Nash JF, Roth BL, Brodkin JD, Nichols DE, Gudelsky GA (1994) Effect of the R(−) and S(+) isomers of MDA and MDMA on phosphatidyl inositol turnover in cultured cells expressing 5-HT2A or 5-HT2C receptors. Neurosci Lett 177:111–115 · DOI
  169. Newman-Tancredi A, Cussac D, Audinot V, Nicolas JP, De Ceuninck F, Boutin JA, Millan MJ (2002) Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D2-like receptor and alpha1/alpha2-adrenoceptor. J Pharmacol Exp Ther 303:805–814 · DOI · Paper page
  170. Nichols DE (2012) Structure-activity relationships of serotonin 5-HT2A agonists. Wiley Interdiscip Rev Membr Transp Signal 1:559–579 · DOI · Paper page
  171. Nichols DE, Pfister WR, Yim GK (1978) LSD and phenethylamine hallucinogens: new structural analogy and implications for receptor geometry. Life Sci 22:2165–2170 · DOI
  172. Nichols DE, Sassano MF, Halberstadt AL, Klein LM, Brandt SD, Elliott SP, Fiedler WJ (2015) N-benzyl-5-methoxytryptamines as potent serotonin 5-HT2 receptor family agonists and comparison with a series of phenethylamine analogues. ACS Chem Neurosci 6:165–1175 · DOI · Paper page
  173. Ouagazzal A, Grottick AJ, Moreau J, Higgins GA (2001) Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains. Neuropsychopharmacology 25:565–575 · DOI
  174. Padich RA, McCloskey TC, Kehne JH (1996) 5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats. Psychopharmacology 124:107–116 · DOI
  175. Palenicek T, Hlinak Z, Bubenikova-Valesova V, Novak T, Horacek J (2010) Sex differences in the effects of N, N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition. Prog Neuropsychopharmacol Biol Psychiatry 34:588–596 · DOI
  176. Pálenícek T, Fujáková M, Brunovskỳ M, Horácek J, Gorman I, Balíková M, et al. (2013) Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats. Psychopharmacology (Berl) 225:75–93 · DOI
  177. Paulus MP, Geyer MA (1991) A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants. Psychopharmacology 104:6–16 · DOI
  178. Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, Henry BL, Zhuang X, Masten VL, Sharp RF, Geyer MA (2009) A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry 66:1072–1080 · DOI · Paper page
  179. Piercey MF, Hoffmann WE, Smith MW, Hyslop DK (1996) Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists. Eur J Pharmacol 312:35–44 · DOI · Paper page
  180. Pranzatelli MR (1990) Evidence for involvement of 5-HT2 and 5-HT1C receptors in the behavioral effects of the 5-HT agonist 1-(2,5-dimethoxy-4-iodophenyl aminopropane)-2 (DOI). Neurosci Lett 115:74–80 · DOI · Paper page
  181. Quednow BB, Kühn K-U, Mössner R, Schwab SG, Schuhmacher A, Maier W, Wagner M (2008) Sensorimotor gating of schizophrenia patients is influenced by 5-HT2A receptor polymorphisms. Biol Psychiatry 64:434–437 · DOI
  182. Quednow BB, Schmechtig A, Ettinger U, Petrovsky N, Collier DA, Vollenweider FX, Wagner M, Kumari V (2009) Sensorimotor gating depends on polymorphisms of the serotonin-2A receptor and catechol-O-methyltransferase, but not on neuregulin-1 Arg38Gln genotype: a replication study. Biol Psychiatry 66:614–620 · DOI
  183. Quednow BB, Kometer M, Geyer MA, Vollenweider FX (2012) Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology 37:630–640 · DOI · Paper page
  184. Rabin RA, Regina M, Doat M, Winter JC (2002) 5-HT2A receptor-stimulated phosphoinositide hydrolysis in the stimulus effects of hallucinogens. Pharmacol Biochem Behav 72:29–37 · DOI
  185. Raffaelli E Jr, Martins OJ, dos Santos P, Dãgua Filho A (1983) Lisuride in cluster headache. Headache 23:117–121 · DOI
  186. Rempel NL, Callaway CW, Geyer MA (1993) Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release. Neuropsychopharmacology 8:201–211 · DOI
  187. Reyes-Parada M, Scorza C, Romero V, Silveira R, Medina JH, Andrus D, Nichols DE, Cassels BK (1996) (±)-1-(2,5-Dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2), a novel putative anxiolytic agent lacking affinity for benzodiazepine sites and serotonin-1A receptors. Naunyn Schmiedebergs Arch Pharmacol 354:579–585 · DOI
  188. Riba J, Rodríguez-Fornells A, Barbanoj MJ (2002) Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively. Psychopharmacology 165:18–28 · DOI
  189. Rigdon GC, Weatherspoon JK (1992) 5-Hydroxytryptamine1a receptor agonists block prepulse inhibition of acoustic startle reflex. J Pharmacol Exp Ther 263:486–493 · DOI · Paper page
  190. Rusterholz DB, Spratt JL, Long JP, Kelly TF (1978) Serotonergic and dopaminergic involvement in the mechanism of action of R-(-)-2,5-dimethoxy-4-bromoamphetamine (DOB) in cats. Life Sci 23:1499–1506 · DOI
  191. Salvatore S, Hyde RW (1956) Progression of effects of lysergic acid diethylamide (LSD). Arch Neurol Psychiat 2:50–59 · DOI
  192. Sanchez C, Arnt J, Moltzen E (1996) Assessment of relative efficacies of 5-HT1A receptor ligands by means of in vivo animal models. Eur J Pharmacol 315:245–254 · DOI
  193. Sard H, Kumaran G, Morency C, Roth BL, Toth BA, He P, Shuster L (2005) SAR of psilocybin analogs: discovery of a selective 5-HT2C agonist. Bioorg Med Chem Lett 15:4555–4559 · DOI
  194. Schlemmer RF Jr, Davis JM (1986) A primate model for the study of hallucinogens. Pharmacol Biochem Behav 24:381–392 · DOI
  195. Schmid CL, Bohn LM (2010) Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivo. J Neurosci 30:13513–13524 · DOI · Paper page
  196. Schmid CL, Raehal KM, Bohn LM (2008) Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo. Proc Natl Acad Sci USA 105:1079–1084 · DOI · Paper page
  197. Schmid Y, Enzler F, Gasser P, Grouzmann E, Preller KH, Vollenweider FX, Brenneisen R, Müller F, Borgwardt S, Liechti ME (2015) Acute effects of lysergic acid diethylamide in healthy subjects. Biol Psychiatry 78:544–553 · DOI · Paper page
  198. Schoepp DD (2001) Unveiling the functions of presynaptic metabotropic glu-tamate receptors in the central nervous system. J Pharmacol Exp Ther 299:12–20 · DOI · Paper page
  199. Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ (1995) (1-(2,5-Dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT)2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J Pharmacol Exp Ther 273:101–112 · DOI · Paper page
  200. Scorza MC, Reyes-Parada M, Silveira R, Viola H, Medina JH, Viana MB, Zangrossi H Jr, Graeff FG (1996) Behavioral effects of the putative anxiolytic (±)-1-(2,5-dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2) in rats and mice. Pharmacol Biochem Behav 54:355–361 · DOI

200 of 255 shown

Cited by

Metadata

Authors
Halberstadt, A. L., & Geyer, M. A.
Venue
Current Topics in Behavioral Neurosciences
Published
2016
Volume
36
Pages
159-199
ISSN
  • 1866-3370 (ISSN-L)
  • 1866-3389
OpenAlex
W2590821743
Cited by
106
References
18
FWCI
28.03
Type
book chapter
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.